Mildred T. Stahlman | Academic Influence

Mildred T. Stahlman's AcademicInfluence.com Rankings

Mildred T. Stahlman

Philosophy

#8407

World Rank

#11786

Historical Rank

#1696

USA Rank

Logic

#6975

World Rank

#8555

Historical Rank

#986

USA Rank

philosophy Degrees

Download Badge

Philosophy

Mildred T. Stahlman's Degrees

Masters Medicine Vanderbilt University

Why Is Mildred T. Stahlman Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Mildred T. Stahlman is an American neonatologist and academic. She worked as a professor of pediatrics and pathology at Vanderbilt University in Nashville, Tennessee. Early life Mildred T. Stahlman was born on July 31, 1922, in Nashville, Tennessee. Her father, James Geddes Stahlman, was a Tennessee newspaper publisher who was opposed to desegregation and was a trustee of Vanderbilt University. Her paternal great-grandfather, Major Edward Bushrod Stahlman, was a German-born railroad executive, the owner of the Nashville Banner, and the developer of The Stahlman.

(See a Problem?)

Mildred T. Stahlman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. (1995) (652)
Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. (2002) (601)
Surfactant Protein-D Regulates Surfactant Phospholipid Homeostasis in Vivo * (1998) (333)
Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. (1987) (323)
Compensatory Roles of Foxa1 and Foxa2 during Lung Morphogenesis* (2005) (275)
Foxa2 regulates alveolarization and goblet cell hyperplasia (2004) (268)
Immunocytochemical localization of human epidermal growth factor/urogastrone in several human tissues. (1985) (233)
Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. (1978) (231)
PaO2 levels and retrolental fibroplasia: a report of the cooperative study. (1977) (227)
Vitamin A Status of Neonates with Bronchopulmonary Dysplasia (1985) (220)
Expression of thyroid transcription factor-1(TTF-1) in fetal and neonatal human lung. (1996) (217)
Pneumonitis and Emphysema in sp-C Gene Targeted Mice* (2003) (210)
Effect of Epidermal Growth Factor on Lung Maturation in Fetal Rabbits (1979) (204)
Biogenesis of lamellar bodies, lysosome-related organelles involved in storage and secretion of pulmonary surfactant. (2002) (202)
Gene Structure and Expression of Human Thyroid Transcription Factor-1 in Respiratory Epithelial Cells (*) (1995) (201)
Plasma vitamin A and retinol-binding protein in premature and term neonates. (1981) (177)
Effects of epidermal growth factor on lung maturation in fetal lambs. (1980) (171)
Beta-catenin regulates differentiation of respiratory epithelial cells in vivo. (2005) (164)
Medical management of small preterm infants with symptomatic patent ductus arteriosus. (1978) (162)
FGF-10 disrupts lung morphogenesis and causes pulmonary adenomas in vivo. (2001) (156)
Developmental expression of SP-A and SP-A mRNA in the proximal and distal respiratory epithelium in the human fetus and newborn. (1993) (153)
Temporal-spatial distribution of SP-B and SP-C proteins and mRNAs in developing respiratory epithelium of human lung. (1994) (151)
Immunolocalization of Surfactant Protein-D (SP-D) in Human Fetal, Newborn, and Adult Tissues (2002) (142)
Foxa2 is required for transition to air breathing at birth. (2004) (142)
Rapid onset of essential fatty acid deficiency in the newborn. (1976) (136)
Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma. (1999) (136)
Pharmacokinetics of indomethacin in the neonate. Relation of plasma indomethacin levels to response of the ductus arteriosus. (1981) (128)
Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice. (1992) (122)
Bronchoalveolar lavage fluid surfactant protein-A and surfactant protein-D are inversely related to inflammation in early cystic fibrosis. (2003) (115)
Lamellar Body Formation in Normal and Surfactant Protein B-Deficient Fetal Mice (2000) (115)
Intracranial hemorrhage in the prematurely born infant. Timing of clots and evaluation of clinical signs and symptoms. (1974) (107)
Ontogeny of neuroendocrine cells in human fetal lung. II. An immunohistochemical study. (1985) (94)
Expression of ABCA3 in Developing Lung and Other Tissues (2007) (94)
Immunocytochemical localization of epidermal growth factor in the developing human respiratory system and in acute and chronic lung disease in the neonate. (1989) (93)
Liver Vitamin A Reserves of Very Low Birth Weight Neonates (1985) (90)
EVIDENCE FOR THE PRESENCE OF LIPOFIBROBLASTS IN HUMAN LUNG (2006) (81)
Identification of early interstitial lung disease in an individual with genetic variations in ABCA3 and SFTPC. (2010) (80)
Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia. (2006) (80)
Fibroblast Growth Factor 18 Influences Proximal Programming during Lung Morphogenesis* (2002) (76)
Prematurity is associated with abnormal airway function in childhood (1989) (76)
TGF‐β1 perturbs vascular development and inhibits epithelial differentiation in fetal lung in vivo (2001) (70)
Studies on Group B β-Hemolytic Streptococcus. II. Effects on Pulmonary Hemodynamics and Vascular Permeability in Unanesthetized Sheep (1981) (70)
Plasma retinol-binding protein response to vitamin A administration in infants susceptible to bronchopulmonary dysplasia. (1990) (66)
PATHOPHYSIOLOGY OF RESPIRATORY DISTRESS IN NEWBORN LAMBS. CIRCULATORY, BIOCHEMICAL, AND PATHOLOGICAL CONSIDERATIONS. (1964) (65)
Red cell volume measurements and acute blood loss in high-risk newborn infants. (1977) (63)
SEVERE BRONCHOPULMONARY DYSPLASIA: A RETROSPECTIVE REVIEW (1983) (63)
Necrotizing Enterocolitis in the Newborn: Operative Indications (1975) (63)
Deletion of Scap in Alveolar Type II Cells Influences Lung Lipid Homeostasis and Identifies a Compensatory Role for Pulmonary Lipofibroblasts* (2009) (62)
Residual pulmonary findings in clinical hyaline-membrane disease. (1968) (61)
Serum vitamin A levels in respiratory syncytial virus infection. (1994) (61)
Laryngeal Chemoreflex in Newborn Lambs: Respiratory and Swallowing Response to Salts, Acids, and Sugars (1979) (59)
Ontogeny of Clara cell-specific protein and its mRNA: their association with neuroepithelial bodies in human fetal lung and in bronchopulmonary dysplasia. (1996) (56)
Vitamin A delivery from parenteral alimentation solution. (1981) (56)
Newborn intensive care: Success or failure? (1984) (54)
Circulatory studies in clinical hyaline membrane disease. (1970) (53)
Conditional deletion of Abca3 in alveolar type II cells alters surfactant homeostasis in newborn and adult mice. (2010) (52)
Distinct effects of oxygen on surfactant protein B expression in bronchiolar and alveolar epithelium. (1992) (52)
Maternal and Fetal Plasma Progesterone, Cortisol, Testosterone and 17β-Estradiol in Preparturient Sheep: Response to Fetal ACTH Infusion1 (1974) (51)
A six-year follow-up of clinical hyaline membrane disease. (1973) (49)
Increased survival rate in very low birth weight infants (1500 grams or less): No association with increased incidence of handicaps (1990) (49)
Studies on infants with type II respiratory distress syndrome. (1971) (49)
Treatment of cardiovascular disorders of the newborn. (1964) (49)
Studies on Group B β-Hemolytic Streptococcus. I. Isolation and Partial Characterization of an Extracellular Toxin (1981) (47)
Recurrence of symptomatic patent ductus arteriosus in extremely premature infants, treated with indomethacin. (1984) (46)
Inhibition of alveolarization and altered pulmonary mechanics in mice expressing GATA-6. (2003) (45)
Effects of Cyclooxygenase Inhibition on the Response to Group B Streptococcal Toxin in Sheep (1983) (45)
Temporal-Spatial Distribution of Hepatocyte Nuclear Factor-3β in Developing Human Lung and Other Foregut Derivatives (1998) (44)
Pulmonary Hemodynamic and Ultrastructural Changes Associated with Group B Streptococcal Toxemia in Adult Sheep and Newborn Lambs (1983) (44)
The ontogeny and distribution of surfactant protein B in human fetuses and newborns. (1992) (44)
Misexpression of ELF5 disrupts lung branching and inhibits epithelial differentiation. (2008) (43)
Prognosis in hyaline-membrane disease. Use of a linear-discriminant. (1967) (43)
The cardiovascular response to laryngeal water administration in young lambs. (1982) (42)
EARLY PREDICTION OF SYMPTOMATIC PATENT DUCTUS ARTERIOSUS FROM PERINATAL RISK FACTORS: A DISCRIMINANT ANALYSIS MODEL (1981) (41)
Role of hyaline membrane disease in production of later childhood lung abnormalities. (1982) (41)
Pulmonary ventilation and diffusion in the human newborn infant. (1957) (40)
Negative pressure assisted ventilation in infants with hyaline membrane disease. (1970) (38)
Calcitonin gene-related peptide in human fetal lung and in neonatal lung disease. (1988) (35)
Increased survival rate in very low birth weight infants (1500 grams or less): no association with increased incidence of handicaps. (1991) (33)
Ethical issues in the nursery: priorities versus limits. (1990) (33)
Ontogeny of epidermal growth factor receptor and lipocortin-1 in fetal and neonatal human lungs. (1990) (33)
The Effects of Postnatal Retinoic Acid Administration on Nephron Endowment in the Preterm Baboon Kidney (2009) (32)
Effect of retinol on fetal lamb tracheal epithelium, with and without epidermal growth factor. A model for the effect of retinol on the healing lung of human premature infants. (1988) (31)
EARLY ONSET GROUP B STREPTOCOCCAL DISEASE. SEVEN YEAR EXPERIENCE AND CLINICAL SCORING SYSTEM (1983) (31)
Ontogeny of Epidermal Growth Factor Receptor/Kinase and of Lipocortin-1 in the Ovine Lung (1989) (30)
Human Surfactant Protein-A Contains Blood Group A Antigenic Determinants (1992) (29)
Serial sonography of posthemorrhagic ventricular dilatation and porencephaly after intracranial hemorrhage in the preterm neonate. (1983) (28)
Cardiovascular response of the neonatal lamb to hypoxia and hypercapnia. (1967) (28)
EFFECT OF POSITIVE‐END‐EXPIRATORY‐PRESSURE ON RIGHT VENTRICULAR OUTPUT IN LAMBS WITH HYALINE MEMBRANE DISEASE (1980) (26)
Ontogeny of neuroendocrine cells in human fetal lung. III. An electron microscopic immunohistochemical study. (1987) (25)
Platelet dysfunction in the neonate with essential fatty acid deficiency. (1977) (25)
Forkhead box A2 transcription factor is expressed in all types of neuroendocrine lung tumors. (2004) (22)
Timing of intracranial bleeding in newborn infants (1971) (22)
Ontogeny of neuroendocrine cells in human fetal lung. I. An electron microscopic study. (1984) (21)
Lipocortin-1 immunoreactivity in the human pituitary gland. (1990) (20)
Ventilation control in the newborn. Carbon dioxide tension and output. (1961) (20)
Hearing, speech, and language outcome in infants with extreme immaturity. (1987) (20)
Anatomical development and maturation of the lungs. (1978) (19)
Disseminated intravascular coagulation and hyaline membrane disease. (1971) (19)
Expression of surfactant protein B precursor and surfactant protein B mRNA in adenocarcinoma of the lung. (1997) (18)
Impact of advances in physiology, biochemistry, and molecular biology on pulmonary disease in neonates. (1998) (17)
THE MANAGEMENT OF RESPIRATORY FAILURE IN THE IDIOPATHIC RESPIRATORY DISTRESS SYNDROME OF PREMATURITY * (1965) (17)
Vitamin A supplementation and bronchopulmonary dysplasia--revisited. (1992) (17)
Colocalization of peptide hormones in neuroendocrine cells of human fetal and newborn lungs: An electron microscopic study (1993) (16)
The role of sonography and the radiologist-ultrasonologist in the detection and follow-up of intracranial hemorrhage in the preterm neonate. (1981) (16)
Plasma 6-keto prostaglandin F1α and thromboxane B2 in sick preterm neonates (1985) (16)
Immunogold EM localization of neurochemicals in human pulmonary neuroendocrine cells (1997) (15)
The occurrence of pulmonaryfibrosis in children who had idiopathic respiratory distress syndrome (1964) (14)
Symptomatic posthemorrhagic anemia in the newborn. (1970) (14)
Cardiovascular adjustments in normal newborn lambs. (1962) (13)
Safety and pharmacokinetics of vitamin A therapy for infants with respiratory syncytial virus infections (1995) (13)
The effects of ACTH on lung maturation in fetal lambs. (1979) (13)
Long time results of respirator therapy. (1970) (13)
The prophylaxis of streptococcal infections in patients with rheumatic fever; a comparison between sulfadiazine and erythromycin. (1959) (12)
A Quantitative Model for Hyaline Membrane Disease (1982) (12)
Intracranial Doppler Flow Velocimetry Compared with Extracranial Carotid Blood Flow Measurements (1986) (12)
Maternal and fetal plasma progesterone, cortisol, testosterone and 17beta-estradiol in preparturient sheep: response to fetal ACTH infusion. (1974) (12)
Vitamin A status and airway infection in mechanically ventilated very‐low‐birth‐weight neonates (1995) (12)
Metabolic evaluation of a synthetic amino acid mixture for parenteral nutrition in infants and children. (1976) (11)
Lung Water and Vascular Permeability in Sheep: Newborns Compared with Adults (1978) (11)
Clinical description of bronchopulmonary dysplasia (1979) (11)
THE ROLE OF CYCLIC AMP IN LAMELLAR BODY SYNTHESIS & SECRETION (1974) (11)
The use of a crystalline amino acid mixture for parenteral nutrition in low-birth-weight infants. (1977) (11)
Circulatory studies in clinical hyaline membrane disease. (1972) (10)
Ethical dilemmas in perinatal medicine. (1979) (10)
Effects of Methylprednisolone on the Response to Group B Streptococcal Toxin in Sheep (1984) (8)
Quantitation of cardiac output components in the presence of bidirectional shunts. (1977) (8)
Medical Complications in Premature Infants (1989) (8)
The Care of Premature Infants : Historical Perspective (2001) (7)
Serum oxaloacetic transaminase activity in acute rheumatic fever; values in cases with and without salicylate therapy. (1958) (7)
Transport of the neonate. (1979) (7)
TGF-alpha perturbs surfactant homeostasis in vivo. (2005) (6)
Conditional deletion of Abca 3 in alveolar type II cells alters surfactant homeostasis in newborn and adult mice (2010) (6)
Pulmonary function in long-term survivors of hyaline membrane disease. (1988) (6)
Reflections on Neonatal Intensive Care in the U.S.: Limited Success or Success with Limits? (2001) (5)
TGF-α perturbs surfactant homeostasis in vivo (2005) (5)
How does Neonatology fit into Maternal and Child Health? (2005) (5)
The effects of hypoxia and hypercapnia on the circulation in newborn lambs (1964) (5)
Clinical description of bronchopulmonary dysplasia. (1980) (5)
Maternal-fetal exchange of 59 Fe: radiation dosimetry and biokinetics in human and sheep studies. (1973) (5)
Changing cognitive outcome in preterm infants with hyaline membrane disease. (1985) (5)
ISOLATION AND IDENTIFICATION OF GROUP B β-HEMOLYTIC STREPTOCOCCAL (GBS) TOXIN FROM SEPTIC NEWBORN INFANTS. • 1796 (1996) (5)
Parenteral Alimentation of Premature Infants Under 1,200 Grams (1973) (5)
Perinatal circulation. (1966) (5)
PaO2 Levels and Retrolental Fibroplasia: A Report of the Cooperative Study (1977) (4)
The relation of disseminated intravascular coagulation to hyaline membrane disease. (1970) (4)
RESPIRATORY REGULATION IN THE NEWBORN * (1963) (4)
Summary Foxa 2 regulates alveolarization and goblet cell hyperplasia (4)
Plasma 6-keto prostaglandin F1 alpha and thromboxane B2 in sick preterm neonates. (1985) (4)
Medical complications in premature infants: is treatment enough? (1989) (3)
EFFECTS OF GROUP B STREPTOCOCCI ON LUNG FLUID BALANCE QUO IN UNANESTHETIZED SHEEP (1977) (3)
1061 PULMONARY VASCULAR AND GRANULOCYTE RESPONSE TO GROUP B STREPTOCOCCAL (GBS) TOXIN (1981) (3)
1728 LUNG WATER AND VASCULAR PERMEABILITY-SURFACE AREA IN LAMBS WITH HYALINE MEMBRANE DISEASE (HMD) (1981) (3)
Metabolic studies on infants withheart failure on a low sodium milk (1964) (3)
Conditional Deletion Of Abca3 In Alveolar Type II Cells Alters Surfactant Homeostasis In Newborn And Adult Mice (2010) (2)
INFLUENCE OF EARLY INDOMETHACIN ON VENOUS ADMIXTURE IN INFANTS WITH HMD (1984) (2)
Ventilation of newborn infants in body respirators. (1962) (2)
Physiologic and biochemical evaluation of infants with idiopathic respiratory distress syndrome (1963) (2)
A HISTORY OF EXCELLENCE (2013) (2)
Medical Ethics and the Law (1986) (2)
Respiratory Distress Syndromes: Molecules to Man (1991) (2)
Care of high-risk infants. (1984) (2)
Newborn intensive care--success, failure and opportunities. (2010) (2)
Studies of total hemoglobin content and blood volume during the first period of life. (1951) (2)
Recovery from the respiratory distress syndrome. (1973) (2)
Lung water and vascular permeability-surface area in newborn lambs delivered by Caesarean section compared with the 3-5 days-old lamb and adult sheep. (1980) (2)
1994 Referees (2004) (2)
Future ethical issues in neonatology. (1987) (2)
Circulatory consequences of pneumoperitoneum in pulmonary emphysema (1953) (2)
Improving health care provision to neonates in the United States. (1991) (2)
THE GOAL : PREVENTION OF BPD (1999) (1)
1146 PLASMA ALKALINE PHOSPHATASE ACTIVITY, NEONATAL RICKETS. WHAT IS NORMAL? (1981) (1)
INCREASED PULMONARY BLOOD FLOW (PBF) DURING ACTH INFUSION IN FETAL LAMBS (1977) (1)
The use of Intralipid in lambs (1974) (1)
Interstitial emphysema and chronic lung disease in post-respirator hyaline membrane disease (1974) (1)
Serial sonographic monitoring of intracranial hemorrhage (ICH) and its sequelae in the preterm neonate. (1983) (1)
ASSESSMENT AND CARE OF NEWBORN PROBLEMS. (1964) (1)
Neonatology in the 1990s and beyond. (1996) (1)
DETECTION OF INTRAVENTRICULAR HEMORRHAGE (IVH) BY TRANSCEPHALIC IMPEDANCE (TCZ) IN PREMATURE INFANTS (1982) (1)
The “Pulmonary Hyaline Membrane” as a Manifestation of Heart Failure in the Newborn Infant (2005) (1)
Pulmonary Pathology in Lambs with Hyaline Membrane Disease Ventilated with Air and 100% O2 (1970) (0)
The Benefits of C-section (1982) (0)
Temporal-Spatial Expression of the HNF-3β in the Developing Human Lung.• 301 (1997) (0)
ASSOCIATION OF PERINATAL FACTORS WITH INTRACRANIAL HEMORRHAGE (ICH) IN THE VERY LOW BIRTHWEIGHT (VLBW) PRETERM NEONATE (1984) (0)
Effects of ethyl alcohol on the laryngeal chemoreflex in newborn lambs. (1980) (0)
Simian Virus 40 Large T Antigen Directed by Transcriptional Elements of the Human Surfactant Protein C Gene Produces Pulmonary Adenocarcinomas in Transgenic Mice 1 (2006) (0)
Hyaline Membrane Disease (1974) (0)
MATERNAL-FETAL TRANSFER OF IRON IN SHEEP. (1971) (0)
BLOOD VOLUME AND HEMORRHAGE TIMING IN NEWBORN INFANTS WITH RESPIRATORY DISTRESS USING THE STABLE TRACER, $sup 50$Cr. (1971) (0)
Acceptance of the 1996 American Pediatric Society John Howland Award: Who Will Save Our Children? (1996) (0)
Use of a 10% l-amino acid solution with glucose in pediatric parenteral nutrition. (1976) (0)
Cardiovascular assessment in hyaline membrane disease (H. M. D.) (1965) (0)
Abnormal Lamellar Body Formation in SP-B Deficient Mice • 308 (1998) (0)
10. Correlation of Pulmonary Histology with the Reappearance of Surface Activity in Hyaline Membrane Disease (1969) (0)
Adjustments in Normal Newborn Lambs (2016) (0)
NONINVASIVE ASSESSMENT OF PATENT DUCTUS ARTERIOSUS (PDA) SHUNT MARNITUDE WITH IMPEDANCE CARDIOGRAPHY (IC) (1977) (0)
37. Low Blood Volume in Infants with Respiratory Distress (1969) (0)
Total hemoglobin and blood volume in the newborn period. (1951) (0)
Circulatory Factors in Relation to Idiopathic Respiratory Distress (Hyaline Membrane Disease) in the Newborn (2010) (0)
The Effect of the Angiotensin Converting Enzyme (ACE) Inhibitors Captopril and Enalapril on the Development of Oxygen Induced Lung Injury in the Rat.† 1563 (1997) (0)
John Lind, M.D. 1909–1983 (1983) (0)
Studies on respiratory infants with type distress syndrome II (1971) (0)
IMMUNOREACTIVE (I-R) SEROTONIN IN THE DEVELOPING HUMAN LUNG (1984) (0)
Pulmonary Lipocytes in the Production of Interstitial Fibrosis. † 1598 (1997) (0)
LARYNGEAL CHEMOREFLEX - NEWBORN APNEA AND SUDDEN INFANT DEATH SYNDROME (SIDS) (1977) (0)
Negative pressure assisted ventilation with hyaline membrane disease in infants (1970) (0)
in the neonate with essential (1977) (0)
Improving health care provision to neonates in the United States. (1991) (0)
Effect of hyaline membrane disease on outcome of premature infants. (1982) (0)
Reply to: Vitamin A for varicella (1994) (0)
Cardiovascular response of the neonatal lamb to acetylcholine. (1967) (0)
Letter: Early versus late initiation of continuous negative pressure in infants with clinical hyaline membrane disease. (1975) (0)
PREDICTION OF SYMPTOMATIC PATENT DUCTUS ARTERIOSUS (sPDA) FROM PERINATAL RISK FACTORS (1977) (0)
Surfactant Structure after the First Breaths in Newborn SP-B Deficient Mice (1999) (0)

This paper list is powered by the following services:

Other Resources About Mildred T. Stahlman

en.wikipedia.org

What Schools Are Affiliated With Mildred T. Stahlman?

Mildred T. Stahlman is affiliated with the following schools:

Image Attributions

Image Source for Mildred T. Stahlman